Aurora Cannabis (TSX:ACB) About to Get Transformed

Here’s why investors in Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) should expect significant transformative news from the marijuana company soon.

| More on:

Marijuana producer and aggressive growth stock Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been in the news lately over its recent connected actions towards strategic partnerships since engaging a professional investment manager, its latest lodging of a $750 million shelf prospectus, and the latest personnel hire, which indicate a serious commitment to business transformation.

The company had lagged behind in forming strategic partnerships with the major players in the alcohol, tobacco, or pharmaceuticals sectors and any other related industries after the rumoured Coca Cola deal did not materialize. Canopy Growth received a $5 billion investment from Constellation Brands, Cronos Group received a $2.4 billion injection from Altria Group, while Tilray and HEXO each signed on strategic partners.

Aurora is now on a serious drive to quickly address the partnership issue. The company signed on multi-billion-dollar hedge fund manager Nelson Peltz as a strategic advisor in March. The connected deal maker could be very instrumental in negotiating accretive partnerships for the company, and a new hire has been availed who will assist him.

Enter the shrewd investment banker

The company has just hired a former investment banker on a full-time basis.

On Thursday, April 4, the company appointed a former managing director of BMO Capital Markets, Mr Carey Squires, as executive vice president, Corporate Development and Strategy in a bid to support strategic initiatives.

The new position will report directly to the executive chair and will “focus on global growth and partnership strategies” and investor development.

Interestingly, the new hire had been a trusted advisor to the company on a several other strategic deals and he comes with deep global investment banking experience. His new employer may greatly benefit from his networks of strategic contacts as it goes on another aggressive growth spate anchored on global partnerships.

I am just wondering how the investment banker’s working week will be like as a full-time employee of a cannabis firm, tasked with “sourcing potential accretive opportunities in the global cannabis industry and negotiating favourable business transactions,” but the new role may generate a significant number of new strategic alliances for the firm if successfully executed.

A brilliant low-cost expansion strategy replay?

Most impressive and unique is the company’s propensity to hire and internalize the best people and teams for its aggressive growth endeavours.

During the productive facility build-out stage when every licensed producer was making frantic efforts to increase productive capacity, the company decided to acquire a global greenhouse design firm Larssen to create its ALPS subsidiary. The transaction saved a lot of cash for engineering consultancy and project management fees and was very strategically accretive, too.

As investor focus has shifted to strategic alliances and partnerships now, the company has hired and internalized the best brains for investment deal negotiation and structuring, and may save on paying hefty cash finder’s fees and consultancy fees.

The company may pay the new executive much less cash than what outside consultants will have charged and offer him more in stock-based compensation while tapping into his rich networks in the investment industry. The result may be very similar to the Larssen acquisition.

Larssen engineers were critical in Green Organic Dutchman and Denmark strategic deals, and the company is on track to becoming a producer of 570,000 kilograms of marijuana per annum.

I’m curious just how many partnerships the company targets to establish through Peltz and Squires for it to rule the global marijuana industry. This could mean a good number of them, and the deals may significantly transform Aurora into the great marijuana stock investors desire.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Paradza has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »